ABIOMED, Inc. (ABMD) financial statements (2021 and earlier)

Company profile

Business Address 22 CHERRY HILL DR
DANVERS, MA 01923
State of Incorp. DE
Fiscal Year End March 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments181192121362230212132
Cash and cash equivalents18119212143394822
Short-term investments   319191164110
Receivables93859170544332
Inventory, net of allowances, customer advances and progress billings82908150352717
Inventory82908150352717
Other undisclosed current assets337269384128740
Total current assets:694636677494327288220
Noncurrent Assets
Operating lease, right-of-use asset10 
Property, plant and equipment17916514511788239
Long-term investments and receivables   3847114
Long-term investments   3847114
Intangible assets, net (including goodwill)194474853464846
Goodwill80323336313332
Intangible assets, net (excluding goodwill)114151517141515
Deferred income tax assets21 
Other noncurrent assets1101188514844
Deferred tax assets, net7871355945
Other undisclosed noncurrent assets22025122    
Total noncurrent assets:735581377292223136118
TOTAL ASSETS:1,4281,2161,054786550424338
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities951089070583850
Accounts payable2433322421910
Accrued liabilities72755746382822
Employee-related liabilities      16
Taxes payable      2
Deferred revenue2119
Debt    1  
Deferred revenue and credits151097
Contract with customer, liability16
Other liabilities45     
Other undisclosed current liabilities      (17)
Total current liabilities:12013210685704739
Noncurrent Liabilities
Long-term debt and lease obligation    16  
Capital lease obligations  16  
Liabilities, other than long-term debt471811121397
Deferred tax liabilities, net11111
Deferred income tax liabilities4 
Other liabilities17911300
Business combination, contingent consideration, liability2591010987
Other undisclosed noncurrent liabilities 1     
Total noncurrent liabilities:471911122997
Total liabilities:16715111797985547
Stockholders' equity
Stockholders' equity attributable to parent1,2611,065937690452369292
Common stock0000000
Treasury stock, value(288)(265)(139)(67)(47)(27)(19)
Additional paid in capital782739691620566509465
Accumulated other comprehensive loss(4)(11)(15)(4)(21)(15)(17)
Retained earnings (accumulated deficit)771602399140(47)(99)(137)
Total stockholders' equity:1,2611,065937690452369292
TOTAL LIABILITIES AND EQUITY:1,4281,2161,054786550424338

Income statement (P&L) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Revenues885841769594445330230
Revenue, net 445330230
Cost of revenue(172)(151)(130)(99)(71)(50)(42)
Cost of goods and services sold(172)(151)(130)(4)(71)(50)(42)
Gross profit:712690640495375279188
Operating expenses(456)(440)(415)(338)  (162)
Other undisclosed operating income (loss)    (285)(214)2
Operating income:257249225157906529
Nonoperating income508393110
Investment income, nonoperating121284200
Other nonoperating income (expense)38(5)30(0)(0)0(0)
Other undisclosed loss from continuing operations before equity method investments, income taxes    (0)  
Income from continuing operations before equity method investments, income taxes:307257263160916629
Other undisclosed income from continuing operations before income taxes    0  
Income from continuing operations before income taxes:307257263160916629
Income tax expense (benefit)(120)(54)(4)(48)(39)(28)85
Net income available to common stockholders, diluted:1872032591125238114

Comprehensive Income ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Net income:1872032591125238114
Other comprehensive income (loss)194(10)16(6)3(17)
Comprehensive income, net of tax, attributable to parent:205207249129464197

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: